Molecular Alterations of Circulating Cell-Free DNA in the Pathological Progression of Hepatocellular Carcinoma

<div>The mutated genes in patients with CHB, LC, and HCC. (a) The number of mutated genes in plasma cfDNA among CHB, LC, and HCC patients. (b) The molecular mutation burden of mutated genes among CHB, LC, and HCC patients (40 genes). CHB, chronic hepatitis B; LC, liver cirrhosis; and HCC, hepatocellular carcinoma.</div>

Journal of Oncology

fig2

Figure 2

Figure 2: Molecular Alterations of Circulating Cell-Free DNA in the Pathological Progression of Hepatocellular Carcinoma 